EODData

MEMBERSHIP REGISTER LOG IN

FRA, 1FW1: WUXI BIOLOGICS UNSP.ADR/2

05 Nov 2025
LAST:

7.750

CHANGE:
 0.00		OPEN:
7.750		HIGH:
7.750		ASK:
0.000		VOLUME:
823
CHG(%):
0.00		PREV:
7.750		LOW:
7.750		BID:
0.000		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
05 Nov 257.7507.7507.7507.750823
04 Nov 257.7507.7507.7507.750823
03 Nov 257.9007.9007.9007.900823
31 Oct 258.0508.0508.0508.050823
30 Oct 257.9507.9507.9507.950823
29 Oct 258.0008.0008.0008.000823
28 Oct 258.0008.0008.0008.000823
27 Oct 258.2008.3008.2008.300823
24 Oct 257.9507.9507.9507.950500
23 Oct 257.6507.6507.6507.650500

COMPANY PROFILE

Name:WUXI BIOLOGICS UNSP.ADR/2
About:WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstream process development through its contract research, development, and manufacturing organization platforms, including WuXiBody, SDArBodY, T cell engager, Single B Cell Cloning Technology, WuXia, WuXiUP, WuXiUI, and WuXiHigh. It engages in the provision of consultation services in relation to the biopharmaceutical technology, international sales contracting services, testing and development of testing technologies, sales and marketing services, production and sales of medicals, and biologics clinical and manufacturing services; production and sale of medicals; vaccine contract development and manufacturing organization (CDMO) and related business; and engages in investment and material supplier activities. It has a research service agreement with BioNTech SE to discover and investigate monoclonal antibodies for developing next-generation therapeutic product candidates. The company was incorporated in 2014 and is headquartered in Wuxi, China.
Sector:Healthcare
Industry:Biotechnology
Address:No. 108, Meiliang Road, Wuxi, China, 214092
Website:https://www.wuxibiologics.com
ISIN:US98260N1081
LEI:5493001TD2TH6VDTJU11

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:32.29 
Forward P/E:26.67 
Price to Sales:0.80 
Price to Book:0.70 
Profit Margin:0.21 
Operating Margin:0.27 
Return on Assets:0.06 
Return on Equity:0.11 
Revenue:2.444B 
EBITDA:803.21M 
Shares:2.023B 
Market Cap:15.678B 

TECHNICAL INDICATORS

MA5:7.881.7%
MA10:7.932.3%
MA20:8.033.6%
MA50:8.043.7%
MA100:7.0510.0%
MA200:6.1925.2%
STO14:15.38 
RSI14:47.73
WPR14:-84.62 
MTM14:-0.20
ROC14:-0.03 
ATR:0.16 
Week High:8.053.9%
Week Low:7.750.0%
Month High:9.1518.1%
Month Low:7.5525.2%
Year High:9.2018.7%
Year Low:3.36131.0%
Volatility:18.27